Innerer Wert von S&P & Nasdaq Kontaktieren

Cingulate Inc. CINGW NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
32/100
1/5 Pass
SharesGrow Intrinsic Value
$2,260,930.00
+10766333233.3%

Cingulate Inc. (CINGW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

Analysten schätzen Gewinn pro Aktie (EPS) von $-9.44 und Umsatz von $0.00B für das nächste Geschäftsjahr.

Gewinn pro Aktie (EPS) Erfolgsbilanz: 2024: tatsächlich $-8.80 vs Schätzung $-9.44 (übertroffen +6.7%). 2025: tatsächlich $-4.13 vs Schätzung $-3.82 (verfehlt -8.1%). Analysten-Genauigkeit: 93%.

GpA-Schätzungen — CINGW

93%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$8.80 vs Est –$9.44 ▲ 7.2% off
2025 Actual –$4.13 vs Est –$3.82 ▼ 7.5% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

Umsatzschätzungen — CINGW

Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Kontaktieren
🎓
SharesGrow Akademie
Lernen Sie inneren Wert zu berechnen und unterbewertete Aktien zu finden.
Wöchentliche Live-Sessions
Nachricht senden